ProMIS Neurosciences Inc.
Developing selective antibody therapies targeting toxic proteins in neurodegenerative diseases.
PMN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- SUITE 200, 1920 YONGE STREET, TORONTO
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company focused on the discovery and development of selective antibody therapies for neurodegenerative conditions. The company's approach centers on creating novel biologic products that precisely target toxic, misfolded proteins, which are considered key drivers of various diseases. Its portfolio of therapeutic candidates addresses a range of conditions, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). ProMIS Neurosciences utilizes its proprietary discovery platform to develop tailored antibody therapies designed to combat these diseases at their source.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ProMIS Neurosciences Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ProMIS Neurosciences Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ProMIS Neurosciences Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
